Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies

被引:12
作者
Morales, AAM
Ducongé, J
Alvarez-Ruiz, D
Becquer-Viart, MDA
Núñez-Gandolff, G
Fernández, E
Caballero-Torres, I
Iznaga-Escobar, N
机构
[1] Ctr Mol Immunol, Havana 11600, Cuba
[2] Univ Havana, Inst Pharm & Food IFAL, Havana, Cuba
关键词
monoclonal antibodies; humanized antibodies radiolabeling; nude mice; biodistribution;
D O I
10.1016/S0969-8051(99)00094-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The anti-human epidermal growth factor receptor (EGF-R) humanized antibody h-R3 (IgG,), which binds to an extracellular domain of EGF-R, was used to evaluate the biodistribution on nude mice xenografted with A431 epidermoid carcinoma cell line. Results are compared with its murine version ior egf/r3 monoclonal antibody (mAb). Twenty-one athymic female 4NMRI nu/nu mice were injected intravenously with 10 mu g/100 mu Ci of Tc-99m-labeled mAbs. The mAb ior C5 that recognizes an antigen expressed preferentially on the surface of malignant and cytoplasm of normal colorectal cells was used as negative control. Immunoreactivity of Tc-99m-labeled mAbs was measured by enzyme linked immunosorbent assay on A431 cell line and the immunoreactive fractions determined by Lindmo method. Among all organs significative accumulation was found in tumor (6.14 +/- 2.50 %ID/g, 5.06 +/- 2.61 %ID/g for murine and humanized mAbs, respectively) 4 h after injection. The immunoreactive fractions were found to be 0.88 and 0.81 for murine and humanized mAb, respectively. Thus, we expect better results using the humanized mAb h-R3 for diagnostic immunoscintigraphy. NUCL MED BIOL 27;2:199 -206, 2000. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 37 条
[1]   TC-99M-LABELED ANTI-CEA MONOCLONAL-ANTIBODY FOR TUMOR IMMUNOSCINTIGRAPHY - 1ST CLINICAL-RESULTS [J].
BAUM, RP ;
HERTEL, A ;
LORENZ, M ;
SCHWARZ, A ;
ENCKE, A ;
HOR, G .
NUCLEAR MEDICINE COMMUNICATIONS, 1989, 10 (05) :345-352
[2]  
BEATTY JD, 1986, CANCER RES, V46, P6494
[3]  
DADPARVAR S, 1994, CANCER-AM CANCER SOC, V73, P884, DOI 10.1002/1097-0142(19940201)73:3+<884::AID-CNCR2820731320>3.0.CO
[4]  
2-U
[5]   PHASE-I AND IMAGING TRIAL OF INDIUM-111-LABELED ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY 225 IN PATIENTS WITH SQUAMOUS-CELL LUNG-CARCINOMA [J].
DIVGI, CR ;
WELT, S ;
KRIS, M ;
REAL, FX ;
YEH, SDJ ;
GRALLA, R ;
MERCHANT, B ;
SCHWEIGHART, S ;
UNGER, M ;
LARSON, SM ;
MENDELSOHN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (02) :97-104
[6]  
DIVGI CR, 1991, NUCL MED BIOL, V18, P705
[7]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[8]   ANTIBODY-GUIDED RADIOLOCALIZATION OF TUMORS IN PATIENTS WITH TESTICULAR OR OVARIAN-CANCER USING 2 RADIOIODINATED MONOCLONAL-ANTIBODIES TO PLACENTAL ALKALINE-PHOSPHATASE [J].
EPENETOS, AA ;
CARR, D ;
JOHNSON, PM ;
BODMER, WF ;
LAVENDER, JP .
BRITISH JOURNAL OF RADIOLOGY, 1986, 59 (698) :117-125
[9]   Micromethod for quantification of SH groups generated after reduction of monoclonal antibodies [J].
Escobar, NI ;
Morales, A ;
Nunez, G .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (05) :641-644
[10]   A NEW MONOCLONAL-ANTIBODY FOR DETECTION OF EGF-RECEPTORS IN WESTERN BLOTS AND PARAFFIN-EMBEDDED TISSUE-SECTIONS [J].
FERNANDEZ, A ;
SPITZER, E ;
PEREZ, R ;
BOEHMER, FD ;
ECKERT, K ;
ZSCHIESCHE, W ;
GROSSE, R .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, 49 (02) :157-165